Our research projects
Find out more about the research projects you're helping us to fund. Together we can beat blood cancer.
Refine results
Targeting specific proteins in AML cancer cells
Dr Radzisheuskaya is seeking to understand the roles of specific proteins so she can develop more effective treatments for people with AML.
Developing new drug treatments for mastocytosis
Professor Nerlov wants to develop a new drug that can effectively target and treat mastocytosis.
Understanding what causes blood cells to become cancerous
Read more about how Dr Payne and Dr Lubin plan to develop a new tool to help find new ways to prevent blood cancers from developing.
Unlocking a new, less harmful way of treating acute myeloid leukaemia (AML)
Professor Lacaud's research is looking to understand more about the KAT6A protein and how it could be used as a kinder treatment for acute myeloid leukaemia (AML).
A new treatment for myeloma
Dr Alanna Green is testing a new drug that could offer a more effective way to treat myeloma and improve patient outcomes.
Using data to understand more about blood cancer
In this project Professor Pettitt will look at data on 700,000 people affected by blood cancer to understand more about the disease.
Using CAR-T cell techniques to treat myelofibrosis
Read more on how Dr Pule is using CAR-T cell techniques provide an alternative and potentially less harmful treatment for young people affected by myelofibrosis.
Understanding the role of mutations in the blood as we get older
Read more about Dr Kirschner's research which aims to identify mutations that occur in our blood cells so people at risk of developing blood cancer can be monitored.
Making CAR-T cell therapy more effective for people with T-cell acute lymphoblastic leukaemia (T-ALL)
Dr Paul Maciocia is working to make CAR-T cell therapy a more effective treatment for people with T-ALL
Finding new ways to identify and treat the most aggressive type of DLBCL
Dr Calado is working to understand more about why some types of DLBCL stop responding to treatment.
Understanding how MALT lymphoma develops
In this research project, Professor Du will investigate how MALT lymphoma develops to try and find new ways to treat it.
Understanding how MPN develops
In this project, Professor Hitchcock wants to understand more about how MPN develops.
Finding new ways to treat lymphoma
In this research project, Dr Hodson is looking for new ways to treat non-Hodgkin lymphoma.
Understanding what causes relapse in people with AML
In this project, Professor Bonnet wants to understand more about the cell that she thinks is responsible for AML returning.
Understanding how some cancer cells are shielded from chemotherapy
Dr Ingo Ringhausen wants to understand more about how CLL cells can resist treatment.
Understanding how Adult T-cell lymphoma develops
In this research project, Dr Maertens wants to understand how a virus can cause a rare type of lymphoma.
Ensuring people with ALL get the most appropriate level of treatment
In this project, Professor Moorman is trying to find markers that can tell clinicians how much treatment someone with ALL needs.
Understanding how chemotherapy impacts quality of life in people with MDS
This research project will help us understand more about how quality of life changes throughout treatment which will allow clinicians to better support people with MDS in the future.
Understanding how CLL progresses
Dr Hoogeboom, King's College London wants to know more about how CLL cells move around the body and start growing.
Understanding how fat cells are involved in myeloma returning
In this research project, Professor Claire Edwards will look at how fat cells are involved in myeloma progressing.
Understanding how childhood B-ALL develops
Professor Enver wants to find out more about how childhood B-ALL develops so he can prevent it from happening or find better ways to treat it.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.